FDA Clearance Tracker · K173480
Crystalsert Lens Delivery System
Last checked: Nov 20, 2026Latest source record: Dec 11, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 11, 2017
Substantially Equivalent
Time to decision
28 days
Received Nov 13, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class I
The decision
- FDA number
- K173480
- Device name
- Crystalsert Lens Delivery System
- Applicant
- Bausch & Lomb, Inc.
- Applicant location
- St. Louis, MO
- Received
- Nov 13, 2017
- Decided
- Dec 11, 2017
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class I
- Regulation
- 21 CFR 886.4300
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MSS. The earliest in FDA's data is K970727, decided Dec 17, 1997.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K173480
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bausch & Lomb, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact Lens510(k)
K262941 · Decided Oct 16, 2026 · 56 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
P240005 · Decided Oct 10, 2024 · 216 days after receipt
Device type: Lens, multifocal intraocular (MFK) · Ophthalmology
K192005 · Decided Oct 4, 2019 · 67 days after receipt
Device type: Folders And Injectors, Intraocular Lens (Iol) (MSS) · Ophthalmology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.